ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADMA ADMA Biologics Inc

盘后交易 11-22 17:24:20 EST

21.18

-0.12

-0.56%

盘后21.15

-0.03-0.14%

17:04 EST

最高21.48	最低20.88	成交量210.39万
今开21.45	昨收21.30	日振幅2.82%
总市值50.07亿	流通市值49.14亿	总股本2.36亿
成交额4,455万	换手率0.91%	流通股本2.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADMA","market":"US","secType":"STK","nameCN":"ADMA Biologics Inc","latestPrice":21.18,"timestamp":1732309200000,"preClose":21.3,"halted":0,"volume":2103852,"hourTrading":{"tag":"盘后","latestPrice":21.15,"preClose":21.18,"latestTime":"17:04 EST","volume":80010,"amount":1694491.22493,"timestamp":1732313051357},"delay":0,"floatShares":231999999,"shares":236390253,"eps":0.280323,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.12,"latestTime":"11-22 17:24:20 EST","open":21.45,"high":21.48,"low":20.88,"amount":44550833.33568,"amplitude":0.028169,"askPrice":21.45,"askSize":15,"bidPrice":21,"bidSize":134,"shortable":3,"etf":0,"ttmEps":0.280323,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"adjPreClose":21.3,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":21.17,"preClose":21.3,"latestTime":"09:22 EST","volume":1463,"amount":31022.506823,"timestamp":1732285328110},"postHourTrading":{"tag":"盘后","latestPrice":21.15,"preClose":21.18,"latestTime":"17:04 EST","volume":80010,"amount":1694491.22493,"timestamp":1732313051357},"volumeRatio":0.805899,"impliedVol":0.4709,"impliedVolPercentile":0.2381},"requestUrl":"/m/hq/s/ADMA/tweets","defaultTab":"tweets","newsList":[{"id":"2484159977","title":"Adma Biologics Inc盘中异动 急速拉升5.02%报20.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484159977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484159977?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:56","pubTimestamp":1732046218,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时56分，Adma Biologics Inc股票出现波动，股价大幅拉升5.02%。截至发稿，该股报20.52美元/股，成交量113.842万股，换手率0.48%，振幅6.19%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.47%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035658a2467efa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035658a2467efa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2484489655","title":"Adma Biologics Inc2024财年第三财季实现净利润35.91百万美元，同比增加1297.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484489655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484489655?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773092,"startTime":"0","endTime":"0","summary":"11月17日，Adma Biologics Inc公布财报，公告显示公司2024财年第三财季净利润为35.91百万美元，同比增加1297.28%；其中营业收入为1.20亿美元，同比增加78.39%，每股基本收益为0.15美元。从资产负债表来看，Adma Biologics Inc总负债1.59亿美元，其中短期债务1.19百万美元，资产负债比为2.46，流动比率为0.08。机构评级：截至2024年11月17日，当前有4家机构对Adma Biologics Inc目标价做出预测，其中目标均价为25.00美元，其中最低目标价为24.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000622a23e0835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000622a23e0835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2483302306","title":"Adma Biologics Inc盘中异动 急速跳水5.00%报19.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483302306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483302306?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:50","pubTimestamp":1731689418,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时50分，Adma Biologics Inc股票出现异动，股价大幅下挫5.00%。截至发稿，该股报19.19美元/股，成交量157.09万股，换手率0.66%，振幅5.35%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为3.81%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116005018abc532c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116005018abc532c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2483332798","title":"Adma Biologics Inc盘中异动 临近收盘股价大跌5.12%报20.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332798?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:44","pubTimestamp":1731617097,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时44分，Adma Biologics Inc股票出现异动，股价急速下跌5.12%。截至发稿，该股报20.37美元/股，成交量215.088万股，换手率0.91%，振幅4.35%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.93%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044457971a6a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044457971a6a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2482453259","title":"ADMA 生物制品公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482453259","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482453259?lang=zh_cn&edition=full","pubTime":"2024-11-09 05:00","pubTimestamp":1731099655,"startTime":"0","endTime":"0","summary":"ADMA 生物制品公司公布截至 9 月 30 日的季度业绩 - 收益摘要ADMA Biologics Inc ADMA.OQ公布的截至9月30日的季度调整后每股收益为15美分，高于去年同期的每股收益1美分。华尔街预期为每股收益 12 美分至 14 美分。ADMA Biologics Inc公布的本季度每股收益为15美分。公司报告的季度净收入为 3591 万美元。ADMA Biologics Inc本季度股价下跌了1.4%，今年迄今为止上涨了336.3%。华尔街对 ADMA Biologics Inc 的 12 个月目标价中位数为 25.00 美元。本摘要由 LSEG 11 月 8 日 09:00 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF2H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"1109038253","title":"异动解读 | ADMA Biologics股价大涨19%背后原因分析","url":"https://stock-news.laohu8.com/highlight/detail?id=1109038253","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109038253?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:01","pubTimestamp":1731096111,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc在今日盘中出现大涨行情,股价最高暴涨19.12%,报21.34美元,成交量和换手率均显著提高,备受市场关注。分析相关消息,本次大涨或与以下几个因素有关:. 最后,在生物技术行业整体温和上涨的背景下,ADMA作为该领域个股,表现突出也较为吸引投资资金流入,从而推高股价水平。综合上述因素,ADMA Biologics本次大涨主因反映了市场对公司业绩和前景预期的乐观,同时也受到相关评级和行业整体氛围的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADMA"],"gpt_icon":0},{"id":"2482364437","title":"美国研究综述-Bath & Body Works、Datadog、Savers Value Village","url":"https://stock-news.laohu8.com/highlight/detail?id=2482364437","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482364437?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:57","pubTimestamp":1731095879,"startTime":"0","endTime":"0","summary":"美国研究综述-Bath & Body Works、Datadog、Savers Value Village路透11月8日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Bath & Body Works、Datadog 和 Savers Value Village。要点 * Bath & Body Works Inc BBWI.N：巴克莱将其股票评级从等权下调至减持 * Datadog Inc DDOG.O：Monness Crespi Hardt将其评级从中性上调至买入  * Montrose Environmental Group Inc MEG.N：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Savers Value Village Inc SVV.N：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF2ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACIW","ACLX","ADMA","ALLO","APPN","BK4023","IE00B894F039.SGD","ABNB","AFRM","BK4157","AMRC","AEE","APA","IE00B66KJ199.SGD","SVV","AGL","AMPL","ACRE","APLE","DDOG","AMN","ASTH","ARLO","BK4196","ALRM","AKA","ACVA","ALB","ANET","ASLE","AMH","ARHS","ACMR","ARRY","BK4094","AIZ","LU0240878834.USD","ATEN","ARQT","BK4116","GOLF","AMLX","ACHR","APD","APP","AWR","IE00B7SZL793.SGD","AKAM","AORT","BK4528"],"gpt_icon":1},{"id":"2481015991","title":"Adma Biologics Inc盘中异动 早盘股价大涨8.22%报21.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481015991","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481015991?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076452,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Adma Biologics Inc股票出现异动，股价急速上涨8.22%。截至发稿，该股报21.34美元/股，成交量60.0551万股，换手率0.25%，振幅8.32%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.31%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822341295bdef7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822341295bdef7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2481983360","title":"Adma Biologics Inc盘中异动 早盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983360?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903475,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Adma Biologics Inc股票出现波动，股价大幅上涨5.15%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.91%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223115a21d29e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223115a21d29e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2480889881","title":"Adma Biologics Inc盘中异动 股价大涨16.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889881?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467963,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分，Adma Biologics Inc股票出现异动，股价急速上涨16.31%。截至发稿，该股报18.97美元/股，成交量65.6089万股，换手率0.28%，振幅4.59%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.06%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121324395bdab18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121324395bdab18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2479032951","title":"Adma Biologics Inc盘中异动 急速跳水5.01%报16.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479032951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479032951?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:16","pubTimestamp":1730387779,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时16分，Adma Biologics Inc股票出现波动，股价急速跳水5.01%。截至发稿，该股报16.11美元/股，成交量54.0634万股，换手率0.23%，振幅4.19%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为3.57%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031231619ab8c0f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031231619ab8c0f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2479564124","title":"Adma Biologics Inc盘中异动 急速上涨5.00%报16.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479564124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479564124?lang=zh_cn&edition=full","pubTime":"2024-10-29 03:19","pubTimestamp":1730143145,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日03时19分，Adma Biologics Inc股票出现异动，股价大幅拉升5.00%。截至发稿，该股报16.60美元/股，成交量159.03万股，换手率0.68%，振幅4.47%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.01%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102903190598e3ee58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102903190598e3ee58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2475395159","title":"Adma Biologics Inc盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475395159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475395159?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:36","pubTimestamp":1728916583,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时36分，Adma Biologics Inc股票出现异动，股价大幅下挫5.00%。截至发稿，该股报16.29美元/股，成交量177.902万股，换手率0.76%，振幅5.02%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.54%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422362398e3c4d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422362398e3c4d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2474466527","title":"Adma Biologics Inc盘中异动 早盘快速下跌5.26%报19.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474466527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474466527?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:31","pubTimestamp":1728567109,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时31分，Adma Biologics Inc股票出现异动，股价急速跳水5.26%。截至发稿，该股报19.25美元/股，成交量36.0598万股，换手率0.15%，振幅2.55%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.07%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102131499719f80b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102131499719f80b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2473991654","title":"Adma Biologics Inc盘中异动 下午盘急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473991654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473991654?lang=zh_cn&edition=full","pubTime":"2024-10-05 03:21","pubTimestamp":1728069665,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日03时21分，Adma Biologics Inc股票出现异动，股价快速上涨5.01%。截至发稿，该股报20.55美元/股，成交量277.515万股，换手率1.19%，振幅4.24%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.16%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050321069719e70a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050321069719e70a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2471380922","title":"Adma Biologics Inc盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471380922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471380922?lang=zh_cn&edition=full","pubTime":"2024-09-30 23:25","pubTimestamp":1727709958,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日23时25分，Adma Biologics Inc股票出现波动，股价急速上涨5.03%。截至发稿，该股报20.36美元/股，成交量158.612万股，换手率0.68%，振幅5.46%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.03%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302325599719da0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302325599719da0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2468530270","title":"Adma Biologics Inc盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468530270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468530270?lang=zh_cn&edition=full","pubTime":"2024-09-19 02:02","pubTimestamp":1726682527,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日02时02分，Adma Biologics Inc股票出现异动，股价大幅拉升5.02%。截至发稿，该股报19.65美元/股，成交量362.518万股，换手率1.56%，振幅5.13%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.67%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091902020798e37f09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091902020798e37f09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2468369902","title":"Adma Biologics Inc盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468369902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468369902?lang=zh_cn&edition=full","pubTime":"2024-09-17 23:33","pubTimestamp":1726587234,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日23时33分，Adma Biologics Inc股票出现异动，股价大幅拉升5.00%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.73%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723335498e37d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723335498e37d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2467578642","title":"Adma Biologics Inc盘中异动 急速拉升5.08%报17.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467578642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467578642?lang=zh_cn&edition=full","pubTime":"2024-09-13 00:56","pubTimestamp":1726160192,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日00时56分，Adma Biologics Inc股票出现异动，股价急速上涨5.08%。截至发稿，该股报17.77美元/股，成交量141.84万股，换手率0.61%，振幅4.64%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.57%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913005633ab636186&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913005633ab636186&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2462237279","title":"Adma Biologics Inc盘中异动 急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462237279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462237279?lang=zh_cn&edition=full","pubTime":"2024-08-27 03:44","pubTimestamp":1724701459,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日03时44分，Adma Biologics Inc股票出现异动，股价大幅下挫5.05%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.36%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270344209719a0e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270344209719a0e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.admabiologics.com","stockEarnings":[{"period":"1week","weight":0.0545},{"period":"1month","weight":0.3593},{"period":"3month","weight":0.1576},{"period":"6month","weight":1.228},{"period":"1year","weight":4.3924},{"period":"ytd","weight":3.7124}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ADMA Biologics, Inc.于2004年6月24日在新泽西州注册成立。该公司是一家端到端的商业生物制药公司，致力于制造、营销和开发专门的生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有特定传染病风险的人。该公司的目标患者群体包括患有潜在免疫缺陷疾病或可能因医疗原因而受到免疫抑制的免疫功能受损个体。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.036203},{"month":2,"riseRate":0.5,"avgChangeRate":-0.013938},{"month":3,"riseRate":0.6,"avgChangeRate":0.097898},{"month":4,"riseRate":0.6,"avgChangeRate":0.007327},{"month":5,"riseRate":0.7,"avgChangeRate":0.076004},{"month":6,"riseRate":0.2,"avgChangeRate":-0.053782},{"month":7,"riseRate":0.7,"avgChangeRate":0.113035},{"month":8,"riseRate":0.3,"avgChangeRate":0.011317},{"month":9,"riseRate":0.2,"avgChangeRate":-0.020319},{"month":10,"riseRate":0.4,"avgChangeRate":-0.051308},{"month":11,"riseRate":0.6,"avgChangeRate":0.086481},{"month":12,"riseRate":0.4,"avgChangeRate":-0.05303}],"exchange":"NASDAQ","name":"ADMA Biologics Inc","nameEN":"ADMA Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADMA Biologics Inc,ADMA,ADMA Biologics Inc股票,ADMA Biologics Inc股票老虎,ADMA Biologics Inc股票老虎国际,ADMA Biologics Inc行情,ADMA Biologics Inc股票行情,ADMA Biologics Inc股价,ADMA Biologics Inc股市,ADMA Biologics Inc股票价格,ADMA Biologics Inc股票交易,ADMA Biologics Inc股票购买,ADMA Biologics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}